You're viewing an archived version of this project. Please visit the new Big Give site to find current fundraising campaigns.
Profiling Genetic Mutations in Bowel Cancer
The vast majority (95%) of bowel cancer occurs sporadically (it doesn't run in the tamily) which makes it hard to treat with conventional chemotherapy drugs. It's therefore vital that we develop an understanding of the changes in the genes that cause bowel cancer.